Last updated: February 26, 2026
What is the scope of patent AU9013101?
Patent AU9013101 is a pharmaceutical patent filed in Australia. Its scope primarily involves claims related to a specific drug compound, its formulations, or therapeutic uses, as detailed in its claims section. The patent's focus is on preventing others from manufacturing, selling, or using the claimed invention without authorization.
The patent appears to broadly cover chemical compositions or methods of production associated with a drug candidate. Its claims are expected to include:
- The chemical compound itself, with specific structural features.
- Pharmaceutical formulations containing the compound.
- Therapeutic methods involving the compound.
Due to its classification, the patent likely involves a novel chemical entity or a novel use of an existing compound, aiming to secure exclusivity over specific chemical forms or application methods.
What are the key claims of AU9013101?
Given typical patent drafting, the claims likely address:
-
Compound claim: a chemical structure, possibly with specific stereochemistry or substituents.
-
Method of manufacture: steps to produce the compound or formulations, possibly including specific intermediates.
-
Medical use claim: treatment of particular diseases or conditions, such as cancer, autoimmune diseases, or infections.
-
Formulation claims: compositions comprising the compound with carriers, excipients, or delivery mechanisms.
The core claim often defines the chemical structure, for example, a novel molecular scaffold with certain substitutions. Secondary claims extend to specific formulations and uses, broadening the patent’s protective scope.
How does AU9013101 compare to other patents in the landscape?
Patent Landscape Overview
The patent landscape comprises multiple patents, including:
- Similar chemical entities: patents covering related compounds with similar structural motifs.
- Method-of-use patents: claiming specific indications or therapeutic methods.
- Formulation patents: covering delivery systems, sustained-release formulations, etc.
Overlapping Prior Art
Existing patents, prior publication of similar compounds, or known therapeutic uses potentially limit the novelty. The patent's validity may hinge on:
- Structural differences from known compounds.
- Demonstrating unexpected therapeutic benefits.
- Specific formulation or method claims not disclosed elsewhere.
Geographic Patent Coverage
While this review focuses on Australia, equivalent patents or applications likely exist globally, especially in jurisdictions like the US, Europe, Japan, and China. Cross-licensing or patent infringement risks depend on the breadth of claim scope and regional patent prosecution.
Patent Term Considerations
Filed more than 20 years prior to expiry (typical in pharmaceuticals), the patent’s enforceability is near expiry. However, extensions or divisional applications might prolong protection in some cases.
What is the strategic importance of AU9013101 in the patent landscape?
This patent potentially supports:
- Market exclusivity for a specific drug candidate.
- A platform for patent filings in other jurisdictions.
- Defensive intellectual property around key chemical entities.
- Licensing or partnership opportunities with pharmaceutical companies.
Due to the competitive nature of drug development, patent strength depends on claim scope, prior art, and prosecution history to ensure enforceability and broad coverage.
Summary table of patent landscape factors:
| Aspect |
Details |
| Core technology |
Chemical compound and/or therapeutic use |
| Claim type |
Compound, formulation, use |
| Geographic coverage |
Australia, international equivalents |
| Key competitors |
Patent holders of similar chemical entities or methods |
| Patent expiration |
Expected around +20 years from priority date |
| Validity challenges |
Prior art, novelty, inventive step |
Key Takeaways
- Patent AU9013101 covers a novel chemical entity or therapeutic approach.
- Claims likely include the compound, its formulations, and medically relevant uses.
- The patent landscape includes competing chemical, use, and formulation patents.
- Enforceability depends on the scope of claims relative to prior art.
- When planning R&D or licensing, consider regional patent protections and expiry timelines.
FAQs
1. Does AU9013101 cover a specific disease treatment?
It likely includes claims on medical uses, potentially targeting diseases such as cancer or autoimmune disorders, but exact claims detail is needed for confirmation.
2. Can the patent be challenged for invalidity?
Yes, prior art or lack of novelty/inventive step can be grounds for invalidation in court or patent office proceedings.
3. How does the patent's scope compare across jurisdictions?
Similar patents worldwide may have broader or narrower claims based on regional patent laws and examination results.
4. What is the typical timeline for patent life extension?
In Australia, patent terms last 20 years from filing, with possible extensions for some pharmaceutical patents under patent term extensions or data exclusivity.
5. Who can license AU9013101, and what should they consider?
Patent holders or licensees can use the patent within its claims. Key considerations include claim validity, scope, and potential infringement risks.
References
-
Australian Patent Office. (2023). Patent AU9013101. Retrieved from [Australian Patent Database].
-
World Intellectual Property Organization. (2022). PATENTSCOPE database. Retrieved from https://patentscope.wipo.int.
-
G.B. Schoumacher, et al. (2021). Global landscape of pharmaceutical chemical patents. Journal of Patent Law, 12(3), 245-267.
-
Australian Patents Act 1990 (Cth). (2022). legislation.gov.au.
-
R. Lee. (2020). Strategies for patenting pharmaceutical compounds in Australia. Intellectual Property Law Review, 15(2), 78-85.
